Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01032928 · ClinicalTrials.gov registry record · Phase 2
Respiratory-Swallow Training in Veterans With Oropharyngeal Cancer
A Phase 2 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT01032928 is a Phase 2 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 30 participants.
The verdict
NCT01032928, a Phase 2 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
Cancers of the head and neck require surgical, radiation, and chemotherapy treatments that are intended to cure the disease. These treatments have toxic effects on muscles and structures that are necessary to swallow safely and efficiently. The resulting swallowing problems (dysphagia) often remain chronic for Veterans and interfere with their ability to eat and drink. The cost burden to the VA health system is high. There is an urgent need to develop rehabilitative treatments that lessen these burdens. The proposed research is designed to test a novel swallowing therapy that includes the coordination of breathing with swallowing. Our study will train medically and surgically treated, chronically dysphagic Veterans with histories of oropharyngeal cancer in a novel therapy that involves both swallowing and respiratory systems. If the therapy is found to be effective, the long term goal of the project is to extend the study to a multi-site, clinical trial and test the longstanding effect of this treatment compared to other swallowing therapies on swallowing function, QOL and cost.
Interventions
- BEHAVIORAL Respiratory-Swallow Phase training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-06 |
| Est. Completion | 2013-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01032928
The ClinicalTrials.gov registry entry for NCT01032928 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Respiratory-Swallow Phase training is the first listed.
NCT01032928 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01032928 about?
NCT01032928 is a clinical study titled "Respiratory-Swallow Training in Veterans With Oropharyngeal Cancer". Cancers of the head and neck require surgical, radiation, and chemotherapy treatments that are intended to cure the disease. These treatments have toxic effects on muscles and structures that are necessary to swallow safely and efficiently. The resulting swallowing problems (dysphagia) often remain ...
What is the current status of trial NCT01032928?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2011-06. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01032928?
The interventions under investigation include: Respiratory-Swallow Phase training (BEHAVIORAL).
Who is sponsoring clinical trial NCT01032928?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.